vidarabine has been researched along with amphotericin b in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (33.33) | 18.7374 |
1990's | 1 (11.11) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (55.56) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Barlough, JE; Scott, FW | 1 |
Kessler, HA; Pottage, JC | 1 |
Bennett, JE; Klym, DM; Kroll, MH; Washburn, RG | 1 |
Matsubara, M | 1 |
Chevrier, S; Houot, R; Lamy, T; Marchand, T; Poullot, E; Revest, M; Tattevin, P | 1 |
Non, LR; Pande, A; Romee, R; Santos, CA | 1 |
1 review(s) available for vidarabine and amphotericin b
Article | Year |
---|---|
Pseudozyma and other non-Candida opportunistic yeast bloodstream infections in a large stem cell transplant center.
Topics: Adult; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cryptococcus; Cytarabine; Dermatomycoses; Echinocandins; Exanthema; Fever; Fungemia; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Idarubicin; Immunocompromised Host; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lipopeptides; Male; Micafungin; Opportunistic Infections; Retrospective Studies; Saccharomyces; Salvage Therapy; Trichosporon; Ustilaginales; Vidarabine; Voriconazole; Yeasts | 2017 |
8 other study(ies) available for vidarabine and amphotericin b
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Effectiveness of three antiviral agents against FIP virus in vitro.
Topics: Amphotericin B; Animals; Antiviral Agents; Cats; Cells, Cultured; Coronaviridae; Ribavirin; Vidarabine; Virus Replication | 1990 |
Inhibition of in vitro HBsAg production by amphotericin B and ketoconazole.
Topics: Amphotericin B; Antigens, Neoplasm; Antiviral Agents; Carcinoma, Hepatocellular; Cell Line; Depression, Chemical; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Hepatitis B; Hepatitis B Surface Antigens; Humans; Ketoconazole; Liver Neoplasms; Neoplasm Proteins; Vidarabine | 1985 |
Rapid enzymatic method for measurement of serum flucytosine levels.
Topics: Aminohydrolases; Ammonia; Amphotericin B; Biological Assay; Chromatography, High Pressure Liquid; Creatinine; Cytosine; Drug Therapy, Combination; Flucytosine; Humans; Saccharomyces cerevisiae; Vidarabine | 1986 |
Protective effects of interferon, various anti-viral drugs and combinations of these on Herpes simplex virus infection in mice.
Topics: Amphotericin B; Animals; Antiviral Agents; Drug Synergism; Female; Herpes Simplex; Interferons; Lipopolysaccharides; Mice; Mice, Inbred ICR; Poly I-C; Vidarabine | 1981 |
Early cryptococcal meningitis following treatment with rituximab, fludarabine and cyclophosphamide in a patient with chronic lymphocytic leukemia.
Topics: Aged; Amphotericin B; Antibodies, Monoclonal, Murine-Derived; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Cryptococcus neoformans; Cyclophosphamide; Drug Therapy, Combination; Fatal Outcome; Flucytosine; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Meningitis, Cryptococcal; Rituximab; Time Factors; Vidarabine | 2013 |